News | Radiation Therapy | September 27, 2017

MedLever Platform to enable interoperability for patient setup and imaging process with MR-guided proton treatment delivery

MedLever and Hong Kong Sanatorium Partner to Streamline Proton Therapy Workflow

September 27, 2017 — MedLever Inc. recently announced the launch of a comprehensive agreement with the Hong Kong Sanatorium & Hospital (HKSH) to use the MedLever Platform to enable interoperability and streamline workflow for proton therapy delivery. MedLever and HKSH are working together to develop the information backbone to support the magnetic resonance (MR)-guided proton therapy solution being developed at HKSH. Additionally, MedLever will support the information management needs for conventional patient setup incorporating MR imaging. The solution will be first deployed in the conventional therapy department to enable simplified workflow, effective connectivity and data exchange among multiple systems.

The novel setup room methodology developed by the HKSH and supported by the MedLever Platform improves efficiency and patient throughput. By joining forces, MedLever and the HKSH are building an infrastructure solution to enable interoperability among disparate imaging and therapy modalities including MR, conventional X-ray, computed tomography (CT) and photon/proton treatment delivery systems from several vendors.

Image-guided patient positioning in the setup room using the MedLever Platform improves patient throughput significantly and permits the flexible use of different imaging modalities including MRI. Ben Yu, Ph.D., head, medical physics and research at HKSH stated that “one of the keys of success is the capability to transfer data between setup room, gantry room and the treatment planning system. We are delighted to have MedLever working with us on this project and making MR-guided radiation therapy using the setup room possible.”

“We wanted a vendor that had experience with Mosaiq and demonstrated development flexibility to adapt to our changing needs here at HKSH,” added George Chiu, M.D., head, radiotherapy. “MedLever has demonstrated the willingness to listen and the flexibility to change throughout our pilot project. We look forward to further collaborations between MedLever and HKSH in enhancing our patient care.”

For more information: www.medlever.com


Related Content

News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
Subscribe Now